Upul Keerthi Bandarage

USPTO Granted Patents = 40 (Patent Applications = 10)

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 9 (Patent Applications = 12)

Average Co-Inventor Count = 9.7

ph-index = 13

Forward Citations = 401(Granted Patents)

Location History:

Newton, MA (US) (2001 - 2013)
Lexington, MA (US) (2006 - 2024)

Company Filing History:

30 out of 1,149

Vertex Pharmaceuticals, Inc.

Paratek Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...

40 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12331057 - Modulators of alpha-1 antitrypsin (2025-06-17),

2. 11884672 - Modulators of alpha-1 antitrypsin (2024-01-30),

3. 11623924 - Modulators of alpha-1 antitrypsin (2023-04-11),

4. 10875855 - Inhibitors of influenza viruses replication (2020-12-29),

5. 10874673 - Inhibitors of influenza viruses replication (2020-12-29),

6. 10183933 - Isoindolinone inhibitors of phosphatidylinositol 3-kinase (2019-01-22),

7. 10039762 - Inhibitors of influenza viruses replication (2018-08-07),

8. 9908878 - Inhibitors of influenza viruses replication (2018-03-06),

9. 9808459 - Inhibitors of influenza viruses replication (2017-11-07),

10. 9676759 - Isoindolinone inhibitors of phosphatidylinositol 3-kinase (2017-06-13),

11. 9518056 - Inhibitors of influenza viruses replication (2016-12-13),

12. 9394302 - Inhibitors of influenza viruses replication (2016-07-19),

13. 9345708 - Inhibitors of influenza viruses replication (2016-05-24),

14. 9051319 - Inhibitors of influenza viruses replication (2015-06-09),

15. 8871774 - Inhibitors of influenza viruses replication (2014-10-28),

Title: Upul Keerthi Bandarage: Pioneering Innovator in the Medical Industry

Introduction: Upul Keerthi Bandarage, a distinguished inventor based in Lexington, MA, stands out in the industry for his relentless pursuit of innovation and dedication to creating solutions for the future. With 39 patents to his name, Bandarage's work continues to inspire and shape the world we live in today.

Latest Patents: Bandarage's latest patents focus on modulators of alpha-1 antitrypsin, providing compounds that are valuable for treating alpha-1 antitrypsin deficiency (AATD). These compounds, along with their different forms and processes for manufacturing them, showcase Bandarage's commitment to addressing crucial medical challenges.

Career Highlights: With an impressive career span, Bandarage has made significant contributions while working at reputable companies such as Vertex Pharmaceuticals, Inc. and Nitromed, Inc. His innovative mindset and expertise have played a pivotal role in developing groundbreaking solutions that have the potential to revolutionize the medical field.

Collaborations: Bandarage has collaborated with talented individuals in his field, including coworkers like Tiansheng Wang and Francois Maltais. These collaborations have led to the creation of impactful inventions and advancements, further solidifying Bandarage's reputation as a pioneering innovator.

Conclusion: Upul Keerthi Bandarage's remarkable journey as an inventor showcases his unwavering dedication to driving innovation and creating a positive impact on society. His groundbreaking work in developing solutions for challenging medical conditions like AATD exemplifies his commitment to shaping a better future for generations to come.

This text is generated by artificial intelligence and may not be accurate.